Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.

Antimicrobial agents and chemotherapy - 1 Apr 2000

Petropoulos C J, Parkin N T, Limoli K L, Lie Y S, Wrin T, Huang W, Tian H, Smith D, Winslow G A, Capon D J, Whitcomb J M

Abstract excerpt

Although combination antiretroviral therapy has resulted in a considerable improvement in the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the emergence of resistant virus is a significant obstacle to the effective management of HIV infection and AIDS. We have developed a novel phenotypic drug susceptibility assay that may be useful in guiding therapy and improving long-term...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Genetic Vectors

Share to Microbial Sensitivity Tests

Share to Reproducibility of Results

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 10722492
DOI: 10.1128/AAC.44.4.920-928.2000
PMCID: PMC89793

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.PMID 10722492Read ↗

A simple and cost-saving phenotypic drug susceptibility testing of HIV-1.Semantic proximity Read ↗

A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1.Semantic proximity Read ↗

Rapid, phenotypic HIV-1 drug sensitivity assay for protease and reverse transcriptase inhibitors.Semantic proximity Read ↗

A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs.Semantic proximity Read ↗

Rapid biochemical assays for phenotypic drug resistance testing of HIV-1.Semantic proximity Read ↗

Resistance of human immunodeficiency virus type 1 to reverse transcriptase and protease inhibitors: genotypic and phenotypic testing.Semantic proximity Read ↗

A single-loop recombinant pseudotyped-virus-based assay to detect HIV-1 phenotypic resistance.Semantic proximity Read ↗

Human immunodeficiency virus drug resistance testing: state of the art in genotypic and phenotypic testing of antiretrovirals.Semantic proximity Read ↗

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.Semantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceSemantic proximity Read ↗

A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope geneSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.